Anglo American lifted by upgrade

The mining firm is up 4.5% after a Swiss investment bank upgraded the stock from ‘neutral’ to ‘buy’.

UBS changed its rating of Anglo American because of the decline in the company’s share price. Ordinarily, a ‘buy’ rating is issued when a company has made a series of successful announcements, such as new products. However, in this instance UBS feels that Anglo American is undervalued.

Over the past year the company’s share price has declined 35%. This compares with a 21% decline for the mining sector as a whole. The Swiss headquartered bank has now increased its price target for Anglo American from 1500p to 1580p.

The firm’s latest quarterly update in October showed some positive signs. Iron ore production came in well below expectations, but this was offset by significant increases in copper and diamond production.

Chinese demand for minerals has stabilised since the most recent trading update from Anglo American, and this has been reflected in commodity prices. I feel the company’s fortunes are now turning.

Anglo American plc chart

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.